We are live on ! Find out more
BA

BlackRock Advisors Portfolio holdings

AUM $98.8B
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
10 Year Est. Return
AUM
$106B
AUM Growth
+$3.62B
Cap. Flow
-$1.47B
Cap. Flow %
-1.39%
Top 10 Hldgs %
14.33%
Holding
3,812
New
177
Increased
783
Reduced
2,146
Closed
145

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$281M
2
AMZN icon
Amazon
AMZN
+$228M
3
TWX
Time Warner Inc
TWX
+$219M
4
LLY icon
Eli Lilly
LLY
+$212M
5
RTX icon
RTX Corp
RTX
+$208M

Sector Composition

Rank Sector Weight
1 Financials 16.44%
2 Healthcare 15.11%
3 Industrials 11.28%
4 Energy 10.95%
5 Technology 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSY icon
2726
Hershey
HSY
$35.4B
$165K ﹤0.01%
1,692
-31
-2% -$3.04K
SCNB
2727
DELISTED
Suffolk Bancorp
SCNB
$165K ﹤0.01%
7,389
-993
-12% -$22K
BELFB
2728
Bel Fuse Inc Class B
BELFB
$3.88B
$164K ﹤0.01%
6,387
-974
-13% -$23.1K
ARO
2729
DELISTED
Aeropostale Inc
ARO
$164K ﹤0.01%
47,099
-6,180
-12% -$26.3K
BBNK
2730
DELISTED
BRIDGE CAPITAL HOLDINGS
BBNK
$164K ﹤0.01%
6,776
-827
-11% -$19.1K
CBEY
2731
DELISTED
CBEYOND INC COM STK
CBEY
$164K ﹤0.01%
16,525
-1,805,340
-99% -$16.8M
KLIC icon
2732
Kulicke & Soffa
KLIC
$5.3B
$163K ﹤0.01%
11,452
NTRS icon
2733
Northern Trust
NTRS
$22.2B
$163K ﹤0.01%
2,531
-53
-2% -$3.27K
PTX
2734
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$163K ﹤0.01%
1,815
+431
+31% +$26.4K
GSIG
2735
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
$163K ﹤0.01%
12,779
-2,915
-19% -$36.7K
MM
2736
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
$163K ﹤0.01%
32,576
-1,343,214
-98% -$6.79M
CSBK
2737
DELISTED
Clifton Bancorp Inc.
CSBK
$163K ﹤0.01%
12,846
+6,379
+99% +$76K
PETS icon
2738
PetMed Express
PETS
$42.5M
$162K ﹤0.01%
12,038
-1,680
-12% -$22.2K
SB icon
2739
Safe Bulkers
SB
$781M
$162K ﹤0.01%
+16,597
New +$144K
SGYP
2740
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$162K ﹤0.01%
39,786
-2,256
-5% -$9.59K
CLAR icon
2741
Clarus
CLAR
$125M
$161K ﹤0.01%
14,383
-1,747
-11% -$19.4K
ENPH icon
2742
Enphase Energy
ENPH
$4.84B
$161K ﹤0.01%
18,808
+10,388
+123% +$84.3K
MAR icon
2743
Marriott International
MAR
$98.7B
$161K ﹤0.01%
2,509
-64
-2% -$3.8K
OKE icon
2744
Oneok
OKE
$58.7B
$161K ﹤0.01%
2,358
-65
-3% -$4.11K
PATK icon
2745
Patrick Industries
PATK
$2.8B
$161K ﹤0.01%
11,674
-203
-2% -$2.44K
TWIN icon
2746
Twin Disc
TWIN
$335M
$161K ﹤0.01%
4,869
-892
-15% -$26.9K
PFC
2747
DELISTED
Premier Financial Corp. Common Stock
PFC
$161K ﹤0.01%
11,214
-2,136
-16% -$29.5K
KMG
2748
DELISTED
KMG Chemicals Inc
KMG
$161K ﹤0.01%
8,927
+1,365
+18% +$22.3K
FUBC
2749
DELISTED
1st United Bancorp (Florida)
FUBC
$161K ﹤0.01%
18,639
-3,241
-15% -$26.1K
NDLS icon
2750
Noodles & Co
NDLS
$90.5M
$160K ﹤0.01%
582
+173
+42% +$47.5K

Similar funds

BlackRock Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, BlackRock Advisors held 3,812 positions worth $106B, up 3.5% from $102B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BlackRock Advisors's Q2 2014 filing shows 177 new, 783 increased, 2,146 reduced and 145 closed positions. Its largest new stake was iShares US Financials ETF: 3,120,594 shares worth $130M. The largest sale was Pfizer, an estimated $281M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.

  • BlackRock Advisors's largest Q2 2014 buy was iShares US Financials ETF: 3,120,594 shares worth $130M.
  • BlackRock Advisors added most to Apple in Q2 2014, an estimated $743M increase.
  • BlackRock Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $281M.
  • BlackRock Advisors fully exited PPL CORP CORP UITS CONSISTING OF PUR CONTRACT JR SUB NTS in Q2 2014, selling an estimated $40.9M.
  • BlackRock Advisors's ten largest holdings make up 14% of its $106B portfolio in Q2 2014.
  • BlackRock Advisors opened 177 new positions and closed 145 in Q2 2014.
  • BlackRock Advisors's portfolio value rose 3.5% quarter-over-quarter to $106B.

Based on BlackRock Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.